TAMPA— A WellCare Health Plans stockholder has gone to court to try to stop the $15.3 billion sale of WellCare to Centene. Seabaugh contends that WellCare executives rushed the sale through, undervalued WellCare’s stock and did not build any protections into the deal to prevent WellCare shareholders if there’s a drop in the price of the Centene shares they…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
AM Best Affirms Credit Ratings of MS Amlin AG and Lloyd’s Syndicate 2001
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News